Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China
· Delayed Price · Currency is CNY 11.22
+0.41 (3.79%)
At close: Mar 10, 2026
SHE:300485 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 81.2 | -68.85 | 102.92 | 204.73 | 402.27 | 154.9 | Upgrade
|
| Depreciation & Amortization | 47.18 | 47.18 | 48.74 | 47.6 | 55.68 | 36.96 | Upgrade
|
| Other Amortization | 0.07 | 0.07 | - | 0.03 | 1.04 | 1.44 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | -0 | -6.65 | -6.57 | -0.17 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.05 | 0.05 | - | 0.04 | -1.06 | 9.03 | Upgrade
|
| Loss (Gain) From Sale of Investments | 108.13 | 108.13 | -160.07 | -212.12 | -318.44 | -40.99 | Upgrade
|
| Provision & Write-off of Bad Debts | -1.17 | -1.17 | -1.59 | -0.61 | - | - | Upgrade
|
| Other Operating Activities | -230.6 | -5.52 | -6.57 | -1.73 | -7.14 | -3.44 | Upgrade
|
| Change in Accounts Receivable | 14.71 | 14.71 | 39.17 | 1.17 | 34.48 | 29.63 | Upgrade
|
| Change in Inventory | 22.36 | 22.36 | -17.97 | 33.96 | 36.52 | 10.59 | Upgrade
|
| Change in Accounts Payable | 37.98 | 37.98 | -7.32 | -8.71 | -38.42 | 63.89 | Upgrade
|
| Change in Other Net Operating Assets | 0.39 | 0.39 | - | 3.45 | - | 3.86 | Upgrade
|
| Operating Cash Flow | 60.95 | 135.97 | 21.21 | 110.43 | 183.3 | 263.73 | Upgrade
|
| Operating Cash Flow Growth | -32.77% | 541.05% | -80.79% | -39.75% | -30.50% | 52.86% | Upgrade
|
| Capital Expenditures | -90.4 | -101.13 | -52.91 | -43.28 | -45.91 | -117.84 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.18 | - | 0.03 | 10.91 | 15.25 | 0.21 | Upgrade
|
| Cash Acquisitions | - | - | - | -4.43 | - | - | Upgrade
|
| Investment in Securities | -84.43 | -99.45 | -48.99 | 29.27 | -674.77 | -238.9 | Upgrade
|
| Other Investing Activities | 69.65 | 25.22 | 15.61 | 39.92 | 42.96 | 9.15 | Upgrade
|
| Investing Cash Flow | -105 | -175.36 | -86.26 | 32.39 | -662.47 | -347.39 | Upgrade
|
| Net Debt Issued (Repaid) | 19.99 | - | - | - | - | - | Upgrade
|
| Issuance of Common Stock | 4.7 | 4.7 | - | - | - | - | Upgrade
|
| Common Dividends Paid | - | -10.59 | -41.4 | -80.88 | -31.31 | -30.02 | Upgrade
|
| Other Financing Activities | - | - | - | 0.72 | - | -1.62 | Upgrade
|
| Financing Cash Flow | 24.69 | -5.89 | -41.4 | -80.16 | -31.31 | -31.64 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.33 | 0.37 | 0.4 | 2 | -0.51 | -1.29 | Upgrade
|
| Net Cash Flow | -19.03 | -44.9 | -106.05 | 64.67 | -510.99 | -116.59 | Upgrade
|
| Free Cash Flow | -29.45 | 34.85 | -31.7 | 67.15 | 137.38 | 145.88 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -51.12% | -5.83% | 138.75% | Upgrade
|
| Free Cash Flow Margin | -7.32% | 8.37% | -6.65% | 9.14% | 13.07% | 13.33% | Upgrade
|
| Free Cash Flow Per Share | -0.06 | 0.07 | -0.07 | 0.14 | 0.29 | 0.30 | Upgrade
|
| Cash Income Tax Paid | 51.04 | 21.71 | 23.57 | 49.22 | 86.67 | 98.35 | Upgrade
|
| Levered Free Cash Flow | -24.01 | 30.21 | -33.15 | 44.63 | 92.42 | 98.25 | Upgrade
|
| Unlevered Free Cash Flow | -24.01 | 30.21 | -33.15 | 44.63 | 92.42 | 98.36 | Upgrade
|
| Change in Working Capital | 56.09 | 56.09 | 37.79 | 79.14 | 57.5 | 106 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.